Ironwood Pharmaceuticals (IRWD) Intangibles (2016 - 2026)

Ironwood Pharmaceuticals (IRWD) has 7 years of Intangibles data on file, last reported at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 30.85% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 30.85% YoY), and the FY2025 full-year result was $2.0 million, down 28.67% from the prior year.
• Intangibles declined to $1.8 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $4.1 million in Q2 2023 to a low of $1.8 million in Q1 2026.
• A 4-year average of $3.0 million and a median of $3.0 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles dropped 20.09% in 2024 and slumped 30.85% in 2026, its largest moves.
• Tracing IRWD's Intangibles over 4 years: stood at $3.7 million in 2023, then decreased by 22.32% to $2.9 million in 2024, then retreated by 28.67% to $2.0 million in 2025, then retreated by 9.9% to $1.8 million in 2026.
• Business Quant data shows IRWD's Intangibles at $1.8 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.